# Angiocrine Fund, LP — Form D

Angiocrine Fund, LP of NASHVILLE, TN, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2013-01-17. The offering totals $4.3M, of which $1.4M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2013-01-17
- Form: D
- Accession: 0000950103-13-000373
- Industry: Pooled Investment Fund
- Exemptions: 06, 3C, 3C.1
- Total offering: $4.3M
- Amount sold: $1.4M
- Remaining: $3.0M
- Minimum investment: $1K
- Investors: 6
- Date of first sale: 2013-01-02
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-190444

## Issuer

- Name: Angiocrine Fund, LP
- CIK: 0001566838
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 112 2ND AVENUE NORTH, NASHVILLE, TN, 37201
- Phone: (615) 880-2313

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| W Bradley Daniel | Executive Officer | NASHVILLE, TN |
| Jeffrey L Port | Executive Officer | San Diego, CA |
| Angelia L Van Vranken | Executive Officer | NAHVILLE, TN |
| - AngioC Management, LLC | Promoter | NASHVILLE, TN |

## More

- [CIK 1566838 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1566838&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000950103-13-000373.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.